dipyridamole has been researched along with Aseptic Necrosis of Femur Head in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golopatiuk, AS | 2 |
| Sharafutdinov, EN | 1 |
2 other studies available for dipyridamole and Aseptic Necrosis of Femur Head
| Article | Year |
|---|---|
[Acid-base equilibrium and blood gases in patients with aseptic necrosis of the femur head during treatment with curantyl (dipyridamole)].
Topics: Acid-Base Equilibrium; Adult; Carbon Dioxide; Dipyridamole; Female; Femur Head Necrosis; Humans; Hyd | 1988 |
[Conservative treatment of aseptic necrosis of the femur head with curantyl].
Topics: Adult; Dipyridamole; Female; Femur Head Necrosis; Humans; Infusions, Intravenous; Isotonic Solutions | 1988 |